SS-31 Peptide Dosing: What Research Shows So Far

There is no universally accepted SS-31 peptide dosing protocol for humans. SS-31, also known as elamipretide, is an investigational mitochondria-targeted tetrapeptide, and the amounts used in research vary widely by species, route, and study goal. Preclinical animal studies most often use 1–5 mg/kg per day, while human trials have relied on weight-based intravenous infusions defined by each protocol rather than a fixed standard.

What SS-31 Is and Why Dosing Is Hard to Pin Down

SS-31 is a short synthetic peptide that accumulates in the inner mitochondrial membrane, where it interacts with cardiolipin, a lipid involved in cellular energy production. Because that mechanism is unusual, researchers have studied it across heart failure, mitochondrial myopathy, kidney injury, and certain eye conditions.

SS-31 is not an approved drug for general human use, so there is no package insert, no FDA-reviewed dose, and no standard schedule. Every number circulating online traces back either to an animal study or to a clinical trial protocol.

Three factors make SS-31 peptide dosing especially difficult to generalize:

• Route. Subcutaneous, intraperitoneal, and intravenous administration produce very different exposure levels.
• Species. Milligrams per kilogram in mice or rats do not convert directly to human doses.
• Study goal. Cardiac, skeletal muscle, and renal endpoints have been studied at different exposures.

Reported SS-31 Dosing Ranges in Published Research

The table below summarizes ranges reported in the literature. These figures are not recommendations and do not describe a safe or effective human dose.

Setting	Reported range	Route	Notes
Rodent preclinical studies	1–5 mg/kg per day	Subcutaneous or intraperitoneal	Most common in published animal work; often daily for days to weeks
Human trials in mitochondrial disease	Weight-based infusion, roughly 0.05–0.25 mg/kg per hour	Intravenous infusion	Duration and schedule set by each trial protocol
Heart failure trials	Similar weight-based infusion ranges	Intravenous infusion	Given over short, supervised periods in clinical settings
Research-use vials (non-clinical)	No established dose	Varies by researcher	Supplied as lyophilized powder in 10 mg or 30 mg vials

How SS-31 Is Prepared and Measured

Most research-use SS-31 ships as a lyophilized powder that must be reconstituted with bacteriostatic water or sterile saline. The final concentration depends entirely on how much diluent is added, so a 30 mg vial can end up at very different strengths.

This is where math errors happen. Many researchers use a peptide dosing calculator to convert powder weight and diluent volume into a consistent per-dose amount, then double-check the result by hand. Reconstituted peptide should be refrigerated, protected from light, and used within the window the supplier specifies.

Note that reported ss-31 peptide injection dosage figures from trials are usually expressed as milligrams per kilogram per hour of infusion. That convention is not interchangeable with a single subcutaneous injection, and treating the two as equivalent is a common mistake.

Pairing SS-31 With Other Peptides

Researchers sometimes look into ss-31 and mots-c together because both peptides are studied in the context of mitochondrial function. They work through different pathways, and no published human trial establishes a combined dosing schedule.

Stacking two unapproved compounds raises the chance of unanticipated interactions and makes it harder to attribute any effect or adverse reaction to a single substance. A clinician should be involved in any decision that combines research peptides.

Side Effects and Safety Considerations

Reported ss 31 side effects in clinical trials have generally been mild. They include injection-site reactions, headache, and transient nausea, with some trials noting more frequent reactions at higher infusion exposures.

SS-31 is not FDA-approved for human use outside of clinical trials, and it is not a lawful dietary supplement ingredient in the United States. Long-term human safety data do not exist for this peptide.

Anyone considering SS-31 should speak with a healthcare professional first, particularly people who take prescription medications, have a diagnosed medical condition, or are pregnant or nursing.

Sourcing, Purity, and Legal Status

SS-31 sold online is typically labeled for research use only. Purity varies significantly between suppliers, and an unverified product may contain truncated sequences, residual solvents, or incorrect concentrations.

If you are searching for where to buy ss-31 peptide, look for a vendor that publishes a third-party certificate of analysis with HPLC purity data and mass spectrometry confirmation for the specific lot. Vendors that do not share testing results are a poor risk.

Buying research peptides for personal use sits in a gray area legally. The FDA has not approved SS-31 for any human indication, and importing unapproved peptides for personal use is not permitted.

Key Takeaways

• There is no standard SS-31 peptide dosing protocol for humans.
• Animal doses of 1–5 mg/kg per day do not translate directly to people.
• Human trials have used supervised, weight-based intravenous infusions.
• Reconstitution and measurement errors are the most common practical problem.
• SS-31 is not FDA-approved, and long-term human safety data are lacking.

COMMON QUESTIONS

Frequently Asked Questions

What is a typical SS-31 peptide dosage for humans?

There is no standard or FDA-approved human dosage of SS-31. Clinical trials have used weight-based intravenous infusions set by each study protocol, while animal research has generally used 1–5 mg/kg per day. Those animal numbers do not convert directly into a human dose.

How is SS-31 usually administered in studies?

In human trials, SS-31 has been given as a supervised intravenous infusion. In preclinical animal work, subcutaneous and intraperitoneal injections are the most common routes. No oral form has been established as reliably absorbed.

Is SS-31 legal to buy in the United States?

SS-31 is sold online as a research-use-only chemical, not as a dietary supplement or approved drug. The FDA has not approved it for any human indication, so personal use and import fall into a legal gray area. Buyers should also verify third-party purity testing before trusting any supplier.